ArticleDiabetology international2026
Phase angle, extracellular to intracellular water ratio, and advanced glycation end products according to four sarcopenia categories and in relation to muscle strength/mass in elderly out-patients with diabetes.
Article in Diabetology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Sarcopenia is classified into normal, presarcopenia, dynapenia, and sarcopenia according to muscle strength/mass. As assessment methods for muscle strength and mass, phase angle (PhA), extracellular water/intracellular water ratio (ECW/ICW), and advanced glycation end products (AGEs) have been developed. We investigated the proportions in elderly outpatients with diabetes and elucidate clinical characteristics, including PhA, ECW/ICW, and AGEs among the four groups. Methods: A cross-sectional study was performed in 695 patients with diabetes aged 65 years or older, who were classified according to the classification proposed by the Asian Working Group for Sarcopenia. Clinical characteristics of the four groups were compared by ANOVA. Associations of grip strength and skeletal muscle index (SMI) with PhA, ECW/ICW, and AGEs and interrelations among grip strength, SMI, PhA, ECW/ICW, and AGEs were analyzed by multiple linear regression analyses. Results: Proportions of those (male/female, %) classified as normal, presarcopenia, dynapenia, and sarcopenia were 42.3/42.9, 30.3/26.6, 19.9/21.0, and 7.4/9.4, respectively. In order from normal, presarcopenia, dynapenia, and sarcopenia, age, ECW/ICW, and AGEs increased, while grip strength, gait speed, and PhA decreased ( Conclusions: PhA, ECW/ICW, and AGEs were significantly different according to the four sarcopenia groups, and ECW/ICW was independently associated with both grip strength and SMI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.